Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study)

Abstract Background Opioid-induced constipation (OIC) is a common symptom in cancer patients treated with opioids with a prevalence of up to 59%. International guidelines recommend standard laxatives such as macrogol/electrolytes and magnesium hydroxide to prevent OIC, although evidence from randomi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	K.R.J. Kistemaker, A. de Graeff, M. Crul, G. de Klerk, P.M. van de Ven, M.P. van der Meulen, L. van Zuylen, M.A.H. Steegers
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2023-03-01
סדרה:	BMC Palliative Care
נושאים:	Opioids Constipation Magnesium hydroxide Macrogol/electrolytes Laxative Cancer
גישה מקוונת:	https://doi.org/10.1186/s12904-023-01143-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!